Aurum Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 0.75 M
as on 16-12-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.20 Cr
as on 16-12-2024
- Satisfied Charges ₹ 13.47 Cr
as on 16-12-2024
- Revenue 29.44%
(FY 2022)
- Profit 104.56%
(FY 2022)
- Ebitda -80.24%
(FY 2022)
- Net Worth 14.11%
(FY 2022)
- Total Assets 31.10%
(FY 2022)
About Aurum Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹21.20 Cr. The company has closed loans amounting to ₹13.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Atul Talwar, Udit Chawla, Bankimchandra Trivedi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PTC043990
- Company No.
043990
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2004
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aurum Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Talwar  | Director | 02-Apr-2009 | Current |
| Udit Chawla | Director | 14-Jun-2019 | Current |
| Bankimchandra Trivedi | Director | 10-Jun-2020 | Current |
| Nareshkumar Shah | Director | 10-Jun-2020 | Current |
| Yogendra Dwivedi | Director | 10-Jun-2020 | Current |
Financial Performance of Aurum Lifesciences.
Aurum Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.44% increase. The company also saw a substantial improvement in profitability, with a 104.56% increase in profit. The company's net worth Soared by an impressive increase of 14.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurum Lifesciences?
In 2022, Aurum Lifesciences had a public holding of 10.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kivi Healthcare Private LimitedActive 15 years 10 monthsAtul Talwar, Udit Chawla and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Oct 2024 | ₹2.15 M | Open |
Hdfc Bank Limited Creation Date: 19 Oct 2024 | ₹1.21 M | Open |
Hdfc Bank Limited Creation Date: 15 Nov 2023 | ₹2.21 M | Open |
How Many Employees Work at Aurum Lifesciences?
Aurum Lifesciences has a workforce of 121 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurum Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurum Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
